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Objectives This study characterizes left ventricular outﬂow tract (LVOT) gradient variability in pa-
tients with hypertrophic cardiomyopathy (HCM) during cardiac catheterization.
Background Management of HCM is directed by the presence and magnitude of LVOT obstruction.
The magnitude and clinical impact of spontaneous variability during a single cardiac catheterization
has not been described.
Methods Fifty symptomatic patients with HCM (mean age 55  15 years; 48% men) underwent
cardiac catheterization with high-ﬁdelity, micromanometer-tip catheters and transseptal measure-
ment of left ventricular pressures. Obstruction was deﬁned as resting LVOT gradient 30 mm Hg
and severe obstruction as 50 mm Hg. Variability in LVOT gradient was calculated as the difference of
the largest and smallest LVOT gradients in the absence of provocative maneuvers or interventions.
Results The largest LVOT gradient was 54.6  56.4 mm Hg. The spontaneous variability in LVOT
gradient was 49.0  53.1 mm Hg (range 0 to 210.8 mm Hg, median 15 mm Hg). Discrepant classiﬁ-
cation of resting LVOT gradient severity was possible in 25 patients (50%). Twenty patients (40%)
with severe obstruction could have been misclassiﬁed with regard to obstruction severity.
Conclusions In patients with HCM, the LVOT gradient ﬂuctuates signiﬁcantly during a single
hemodynamic assessment. Spontaneous variability could lead to misclassiﬁcation of obstruction
severity in one-half of studied patients. The dynamic nature of LVOT obstruction must be con-
sidered when assessing resting hemodynamics or the success of a given intervention during
cardiac catheterization. (J Am Coll Cardiol Intv 2011;4:704–9) © 2011 by the American College
of Cardiology Foundation
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705Hypertrophic cardiomyopathy (HCM) is a genetically and
phenotypically diverse disease characterized by prominent
myocardial hypertrophy and accompanying LVOT obstruc-
tion in most patients (1–4). The physiology underlying left
ventricular outflow tract (LVOT) hemodynamics in HCM
is complex and dependent on a myriad of clinical factors
(4–8). Thus, LVOT obstruction severity has the potential
for substantial variation and, indeed, has been shown to
fluctuate significantly over the course of days (4,9).
Ascertaining the magnitude of LVOT obstruction is of
clinical utility, as the degree of obstruction is inherent to
symptom etiology and serves as a prognostic indicator
(10–19). In patients refractory to pharmacotherapy, consid-
eration of septal reduction therapy is guided by the presence
of severe LVOT obstruction (15). Furthermore, determina-
tion of successful septal reduction is often assessed by quanti-
fication of post-procedural LVOT gradient (12,20–25). How-
ever, the magnitude of spontaneous gradient variability
during a single cardiac catheterization study has not been
described, which may complicate accurate assessment of
gradient. Therefore, this study was performed to examine
the spontaneous variability of LVOT gradient in patients
with HCM undergoing cardiac catheterization.
Methods
Study population. Between January 2006 and July 2009, 50
patients with HCM were evaluated at the Mayo Clinic in
Rochester, Minnesota. Those patients met the following
criteria: 1) absence of aortic valvular disease; 2) cardiac
catheterization with high-fidelity, micromanometer-tip
catheters (Millar Instruments, Houston, Texas) for
LVOT gradient assessment; 3) transseptal catheteriza-
tion to avoid catheter entrapment (26); 4) transthoracic
echocardiography imaging including LVOT character-
ization before cardiac catheterization; 5) normal sinus
rhythm; and 6) informed consent provided. Reasons for
cardiac catheterization were percutaneous septal alcohol
ablation in 14 patients and further characterization of the
LVOT gradient in the remaining 36 patients. The
diagnosis of HCM was based on the presence of myocardial
hypertrophy in the absence of local or systemic etiologies
(27,28) and had been verified via 2-dimensional Doppler
transthoracic echocardiography. Measurements of septal
thickness and septal morphology were performed as previ-
ously described (29). This study was approved by the Mayo
Clinic Institutional Review Board. All patients provided
informed consent for review of their medical record in
accordance with Minnesota law.
Invasive hemodynamic study. All invasive studies were per-
formed in a fasting state with conscious sedation. Cardio-
active medications were continued the day of the procedure.
Femoral venous access was used to gain access to the right
heart, and left heart pressure measurements were performed Lvia transseptal puncture using 7- or 8-F catheters. Left
ventricular pressure measurements were taken in conjunc-
tion with cineangiography to avoid catheter entrapment and
associated erroneous pressure readings (30). Central aortic
pressure was obtained from retrograde femoral artery access
with 6- or 7-F catheters. High-fidelity, micromanometer-
tip catheters (Millar Instruments) were used in all patients
as previously described (31).
Baseline invasive data were acquired before septal alcohol
ablation or administration of cardiotropic medications. The
LVOT gradient was calculated as the difference between the
peak left ventricular systolic pressure and the peak central
aortic pressure. The largest and smallest resting LVOT
gradients during sinus rhythm for the study were recorded,
and spontaneous LVOT gradient variability was defined as
the difference between these values. For all studies, the
gradient after a premature ventricular contraction (PVC)
was also recorded.
Data analysis. LVOT obstruction was defined as a resting
VOT gradient of 30 mm Hg, with severe obstruction
efined as 50 mm Hg (15). Continuous variables were
xpressed as mean  SD. Correlation of continuous vari-
bles was examined via the
pearman rank correlation coef-
cient given a nonparametric dis-
ribution of covariates. The Wil-
oxon signed-rank test was used
o assess the relationship between
VOT gradient variability and
ategorical variables. Statistical
ignificance was set a priori at p
.05.
esults
Baseline characteristics. Clinical characteristics of the study
population are listed in Table 1. The mean age of the
population was 55  15 years. Most patients (n  45, 90%)
ad moderately severe or severe dyspnea (New York Heart
ssociation class III or IV). Basal septal hypertrophy was
oted in most patients (n  33, 66%). Moderate mitral
egurgitation was present in 11 patients (22%); no patients
ad mitral regurgitation of higher severity.
LVOT gradient characterization. Hemodynamic findings at
ardiac catheterization are shown in Table 2. The largest
esting LVOT gradient was 54.6  56.4 mm Hg, with 28
atients (56%) found to have a gradient 30 mm Hg.
ost-PVC LVOT gradient was 73.8 61.6 mm Hg for the
ntire population.
The spontaneous LVOT gradient variability was 49.0 
3.1 mm Hg (range 0 to 210.8 mm Hg, median 15 mm Hg).
igures 1 and 2 show hemodynamic tracings from individ-
al patients with marked spontaneous LVOT variability.
Abbreviations
and Acronyms
HCM  hypertrophic
cardiomyopathy
LVOT  left ventricular
outflow tract
PVC  premature ventricular
contractionargest and smallest LVOT gradients during sinus rhythm
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706for all study participants are shown in Figure 3. Twenty-five
patients (50%) had resting obstruction (gradient30 mm Hg)
t the time of their largest LVOT gradient measure with a
mallest LVOT gradient measure that was 30 mm Hg.
argest and smallest LVOT gradient measures were taken
t a mean of 7.7 10.6 min apart. The spontaneous LVOT
radient variability was significantly associated with post-
VC LVOT gradient (Spearman rho  0.60, p  0.0001).
There was no significant correlation of LVOT gradient
variability with septal morphology, maximum septal thick-
ness, age, heart rate, double product, left ventricular ejection
fraction, sex, degree of mitral regurgitation, New York
Heart Association functional class, family history of HCM or
sudden cardiac death, history of permanent pacemaker or
implantable cardioverter-defibrillator placement, history of
syncope or pre-syncope, or outpatient use of any studied
cardioactive medications.
A severe resting LVOT gradient was found in 21 patients
(42%), with LVOT gradient 109.7  44.8 mm Hg in this
subgroup. Twenty patients (95% of those with severe obstruc-
tion) had the potential for discrepant severity classification,
given a smallest LVOT gradient measure of 50 mm Hg.
iscussion
This study analyzed spontaneous LVOT gradient variability
in symptomatic patients with HCM during a single cardiac
Table 1. Baseline Characteristics
Age, yrs 55 15
Male 24 (48)
NYHA functional class III or IV 45 (90)
Pre-syncope or syncope 21 (42)
History of atrial ﬁbrillation 3 (6)
Permanent pacemaker 7 (14)
Internal cardioverter-deﬁbrillator 8 (16)
Family history of HCM 12 (24)
Family history of SCD 3 (6)
Mitral regurgitation, moderate 11 (22)
Maximum ventricular wall thickness, mm 20.9 5.1
Left ventricular ejection fraction, % 69 8
Maximum septal thickness, mm 20.1 5.1
Basal septal hypertrophy, % 33 (66)
Prior septal reduction 3 (6)
Medications
Beta-receptor antagonist 42 (84)
Calcium-channel blocker 24 (48)
ACE inhibitor or ARB 14 (28)
Disopyramide 6 (12)
Amiodarone 1 (2)
Values are mean SD or n (%).
ACE  angiotensin-converting enzyme; ARB  angiotensin-receptor blocker; HCM  hyper-
trophic cardiomyopathy; NYHA New York Heart Association; SCD sudden cardiac death.catheterization with high-fidelity, micromanometer-tipcatheters performed for either diagnostic hemodynamic
evaluation or percutaneous septal ablation. The largest
resting LVOT gradient was found to be 54.6  56.4 mm Hg
with LVOT gradient variability 49.0  53.1 mm Hg over
a short period (on average 8 min). One-half of the
study population (50%) had fluctuation in their LVOT
gradient measurement to a degree that their classification
as severe versus nonsevere obstruction varied during a
single study.
Defining the nature and degree of LVOT obstruction is
a fundamental aspect of prognostic and therapeutic decision
making in patients with HCM (14–16,18). It has been well
demonstrated and clinically accepted that the presence of
obstruction is associated with increased cardiac morbidity
and mortality (32). On this basis, pharmacotherapy in
HCM has predominantly focused on alleviation of obstruc-
tive physiology. When severe obstruction is present and
refractory to medical management, septal reduction is war-
ranted, either via surgical myectomy or percutaneous alcohol
ablation (10–13,17). Obstruction has been defined as an
LVOT gradient in excess of 30 mm Hg (15). Septal
reduction therapy is usually performed for severely symp-
tomatic patients with severe obstruction 50 mm Hg.
Measures of LVOT gradient are most often obtained from
a single study in clinical practice, commonly via echocar-
diographic or cardiac catheterization assessment. Although
studies have demonstrated significant fluctuations in LVOT
gradient over the course of days (4,9), before the present
study, the degree of fluctuation within a single hemody-
namic study has not been elucidated.
LVOT obstruction is dynamic in nature and augmented
by any process leading to alteration of left ventricular
loading conditions or myocardial contractility. Indeed,
LVOT gradient variability has been associated with fluctu-
ations in volume status, autonomic nervous activity, diurnal
variation, pharmacotherapy, exercise, general anesthesia,
conscious sedation, recent cardioplegia, and even physical
positioning during gradient assessment (4–8). This study
demonstrates a significant degree of spontaneous LVOT
gradient fluctuation during a single invasive hemodynamic
Table 2. Hemodynamic Variables at Cardiac Catheterization
Systolic blood pressure, mm Hg 128.0 25.5
Diastolic blood pressure, mm Hg 71.7 12.9
Heart rate, beats/min 70 12
Double product, mm Hg/min 8,957 2,467
Largest LVOT gradient, mm Hg 54.6 56.4
Smallest LVOT gradient, mm Hg 5.7 17.3
Post-PVC LVOT gradient, mm Hg 73.8 61.6
Spontaneous LVOT gradient variability, mm Hg 49.0 53.1
Values are mean SD.LVOT left ventricular outflow tract; PVC premature ventricular complex.
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707measure, with interval measurements taken over the course
of minutes.
If patients have symptoms suggestive of obstructive phys-
iology without clear resting gradient at a single noninvasive
study, this may reflect the substantial variability in resting
LVOT gradient that has been demonstrated herein. Thus, it
is important to perform provocative maneuvers on patients
with symptoms and a low resting LVOT gradient. Indeed,
our data demonstrate a significant correlation between
Figure 1. Beat-to-Beat Left Ventricular Outflow Tract Gradient Variability
Continuous high-ﬁdelity left ventricular and aortic hemodynamic tracings dem
tract gradient.
Figure 2. Spontaneous Variability in Left Ventricular Outflow Tract Gradien
Substantial spontaneous variability is noted in the left ventricular outﬂow trac
patient was 113.6 mm Hg with spontaneous complete absence of gradient during thpost-PVC LVOT gradient and resting LVOT gradient
variability. The magnitude of spontaneous gradient variabil-
ity was not correlated with baseline echocardiographic or
clinical parameters.
Study limitations. The present analysis focused on a symptom-
tic HCM patient population and may not be generalizable to all
atients with HCM. Regardless, recognition of dynamic, clinically
ignificant fluctuations in LVOT gradient is likely underappreci-
ted and may have a substantial impact on diagnostic and
te marked respiratory and beat-to-beat variability in left ventricular outﬂow
ient during a single cardiac catheterization. The largest LVOT gradient in thisonstrat
t grad
e same study.
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708therapeutic decision making. Meticulous care was used to avoid
catheter entrapment using the left ventricular inflow pressures, but
this remains a possible confounding problem in these patients
with small hyperdynamic left ventricular cavities.
Conclusions
This study illustrates the spontaneous variability of LVOT
gradient in patients with HCM. A single measurement of
LVOT gradient may not be sufficient to determine an
appropriate management approach, as 50% of studied pa-
tients had variation in the presence of obstruction during a
single hemodynamic evaluation. Given the dynamic nature
of LVOT gradient obstruction, resting evaluation may still
underappreciate clinically significant exercise-induced
LVOT obstruction. Thus, provocative maneuvers to elicit
severe obstruction should be performed in all patients under-
going a hemodynamic evaluation in whom a severe obstruction
is not present. The variable obstruction and labile hemody-
namics in hypertrophic cardiomyopathy must be considered for
diagnostic and therapeutic decision making.
Reprint requests and correspondence: Dr. Rick A. Nishimura,
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